Clinical Trial Update: Safety and Efficacy of Lotemax Versus FML in Subjects Undergoing PRK for the Correction of Mild to Moderate Myopia, 3- Month Follow-up Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Loteprednol etabonate (Lotemax) to fluorometholone (FML) for safety and efficacy in PRK patients with mild to moderate myopia. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• FML (Fluorometholone)
• Lotemax (Loteprednol etabonate)

Snippet

Sponsor: Dr Salouti Eye Research Center | Conditions: Must be PRK Candidate | Phase 4 | Status: UNKNOWN